Jan Schadrack

The burden of chronic low back pain with and without a neuropathic component: a healthcare resource use and cost analysis

Maneesha Mehra, Kala Hill, D. Nicholl et al. · Journal of Medical Economics · 2011 · 153 citations · Full text

The anti-craving compound acamprosate acts as a weak NMDA-receptor antagonist, but modulates NMDA-receptor subunit expression similar to memantine and MK-801

Gerhard Rammes, Beatrice Mahal, Jörg Putzke et al. · Neuropharmacology · 2001 · 150 citations

Weak Nmda-receptor Antagonist, Biochemistry, Functional Selectivity +8

Adherence and Satisfaction of Smartphone- and Smartwatch-Based Remote Active Testing and Passive Monitoring in People With Multiple Sclerosis: Nonrandomized Interventional Feasibility Study

Luciana Midaglia, Patricia Mulero, Xavier Montalbán et al. · Journal of Medical Internet Research · 2019 · 129 citations · Full text

Opioid and dopamine antagonist drug challenges in untreated restless legs syndrome patients

Juliane Winkelmann, Jan Schadrack, Thomas C. Wetter et al. · Sleep Medicine · 2001 · 123 citations

Pain Medicine, Medicine, Neuropharmacology +8

Effects of Kelatorphan and morphine before and after noxious stimulation on immediate-early gene expression in rat spinal cord neurons

Thomas R. Tölle, Jan Schadrack, José Manuel Castro‐Lopes et al. · Pain · 1994 · 104 citations